Invention Grant
- Patent Title: Peptides derived from NCAPG2 and their use
- Patent Title (中): 衍生自NCAPG2的肽及其用途
-
Application No.: US15185796Application Date: 2016-06-17
-
Publication No.: US09562084B2Publication Date: 2017-02-07
- Inventor: Kyungtae Kim , Byung Il Lee , Jae Hyeong Kim
- Applicant: NATIONAL CANCER CENTER
- Applicant Address: KR Goyang-si
- Assignee: NATIONAL CANCER CENTER
- Current Assignee: NATIONAL CANCER CENTER
- Current Assignee Address: KR Goyang-si
- Agency: Vorys, Sater, Seymour & Pease LLP
- Agent Mih Suhn Koh
- Priority: KR10-2014-0005149 20140115; KR10-2014-0089159 20140715
- Main IPC: C07K14/47
- IPC: C07K14/47 ; G01N21/64 ; G01N33/573 ; G01N33/50 ; A61K38/00

Abstract:
NCAPG2, a component of condensin complex II, protein and novel peptides derived from the protein are provided. The peptide may include a fragment of the NCAPG2 protein. The peptide may be a peptide including a fragment of NCAPG2 protein having the amino acid sequence of SEQ ID NO: 7, wherein the fragment includes the amino acid residue number 805 or 1010 of SEQ ID NO: 7, a peptide having the sequence of SEQ ID NO: 8, or a peptide having the sequence of SEQ ID NO: 11. The protein or peptides can be used for preparing and screening pharmaceutical compositions for treating diseases or disorders associated with abnormal cell division including cancer.
Public/Granted literature
- US20160347801A1 PEPTIDES DERIVED FROM NCAPG2 AND THEIR USE Public/Granted day:2016-12-01
Information query